from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1553/frdB

LFCtreatmentdescriptionclass of inhibitor

-0.054

Amikacinug/mL Amikacintranslation

1.240

Cap5-10ug/mL Capreomycintranslation

-0.527

Rox10-50 ug/mL Roxithromycintranslation

-0.525

SM2-5 ug/mL Streptomycintranslation

-0.593

Tet5-10 ug/mL Tetracyclinetranslation

1.117

Rif0.2-5ug/mL Rifampicintranscription

0.561

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.647

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.271

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.039

CPZ10-50 ug/mL Chlorpromazinerespiration

0.118

Clofazimine10-13 ug/mL Clofaziminerespiration

0.643

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.038

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.931

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.238

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.904

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.583

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.953

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.999

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.211

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.698

Nigericin50 uM Nigericinrespiration

0.010

TRC10-150 ug/mL Triclosanrespiration

1.107

TRZ10-25 ug/mL Thioridazinerespiration

-0.355

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.433

menadione6-10 ug/mL Menadionerespiration

0.562

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.305

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.504

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.701

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.413

NRP_1Non-replicating persistence stage 1dosRassociated

0.279

Amp0.2mg/mL AmpicillincellWall

0.128

Cephalexin20-100 ug/mL CephalexincellWall

2.020

Cerulenin0.32-5 ug/mL CerulenincellWall

0.559

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.366

EMB10-20 ug/mL EthambutolcellWall

-0.301

Eta12-40 ug/mL EthionamidecellWall

-0.229

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.450

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.184

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.181

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.473

BZA0.12 mg/mL BenzamidearomaticAmides

-0.407

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.417

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.024

H2O24 mM hydrogen peroxideDNAdamaging

-0.173

Levo10 ug/mL LevofloxacinDNAdamaging

-0.626

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.809

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.164

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.575

UVUV-irradiationDNAdamaging

0.062

ARP41-4 ug/mL Antitubercular compound ARP4?

0.186

Antimycin12.5-50 ug/mL Antimycin A?

-1.220

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.282

PA_110-50 ug/mL Antitubercular compound PA-1?

0.975

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.245

PA8240.2-2 ug/mL PA-824?

-0.693

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.433

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.330

Verapamil50 uM Verapamil?

-0.177

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.272

methoxatin10-20 ug/mL Methoxatin?